The clinical symptoms, severity, and penetrance of sialidosis appear to correlate with the types of NEU1 mutations, which closely reflect the overall biochemical properties of sialidase, including the levels of residual sialidase activity. This evidence concerns the gene NEU1 and sialidosis.